Clascoterone cream was submitted for review to Health Canada in August 2022, with hopes of approval within 3-6 months. It may potentially enhance finasteride's effects for hairlosstreatment.
Finasteride is discussed as a hairlosstreatment with benefits like reduced prostate enlargement and skin aging, but it is not seen as a "fountain of youth." Users report mixed experiences, including side effects like decreased libido and dry eyes.
PP405 shows promise as a hairlosstreatment, with 31% experiencing increased hair density in a short trial. It may complement treatments like finasteride and minoxidil, but long-term effectiveness and safety need confirmation.
The conclusion of this conversation about hairloss is that the user, y00sh420, tried various treatments including a $700 lllt helmet, topical minoxidil and finasteride, spectraDNC, and micro needling, but did not achieve the desired results. They have decided to stop trying until a cure for male pattern baldness is found. Other users expressed different opinions on hairlosstreatments.
This conversation is about various treatments for hairloss, including taking Oral Minoxidil and Finasteride pills. It discusses different prices and sources of these medications in different countries.
People are discussing the potential of a new hairlosstreatment, pp405, and its approval timeline, comparing it to existing treatments like Minoxidil and finasteride. There is skepticism about its effectiveness and concerns about the time it will take for approval and availability, especially in Europe.
The user is experiencing significant hairloss and is considering treatments like minoxidil, finasteride, and possibly a hair transplant. They are advised to consult a dermatologist and consider oral minoxidil and dutasteride, while being aware of potential side effects and the need for ongoing treatment.
A 19-year-old experienced significant hairloss, improved with minoxidil, and is considering adding finasteride to his routine. He is concerned about future hairloss and potential side effects of finasteride.
A 32-year-old man from Vietnam, at Norwood 7 hairloss, is using Minoxidil, Finasteride, rosemary oil, NMN, and CoQ10 to regrow hair. Despite minor improvements, alternatives like hair systems or accepting baldness are suggested due to advanced hairloss.
Deoxyribose sugar gel is discussed as a potential hairlosstreatment, but it lacks human trials and credible evidence. Users express skepticism and humor about its effectiveness compared to established treatments like minoxidil and finasteride.
People are discussing obtaining and testing PP405 for hairlosstreatment, with concerns about its purity and effectiveness. Some are considering delaying hair transplants, while others suggest using existing treatments like finasteride and minoxidil.
The conversation discusses the potential of PP405 as a hairlosstreatment, with some users expressing skepticism and others hopeful about its development. There is also mention of other treatments like Minoxidil, Finasteride, and Pyrilutamide, with users debating the effectiveness and safety of self-experimentation versus waiting for clinical trial results.
The conversation discusses the effectiveness and safety of hairlosstreatments, specifically RU58841 and Pyrilutimide (Pyril), with users sharing that Pyril was no more effective than a placebo and expressing concerns about the safety of RU58841 based on personal experiences and the lack of pharmaceutical interest.
Topical spironolactone is gaining attention as an alternative hairlosstreatment, but it's not as effective as other options like finasteride. Oral spironolactone can cause side effects in men, and there are better topical alternatives like RU, Pyril, and CB.
User experiencing hairloss tried Minoxidil, Finasteride, Microneedling, Ketoconazole shampoo, and Biotin. Others suggest continuing current treatment for 1-2 years before considering Dutasteride and RU58841.
A user is testing clascoterone (Winlevi) on their scalp for hairloss and has noticed a reduction in scalp sebum after one month. They are also using other unspecified treatments and plan to provide an update after the second month.
The conversation discusses the use of finasteride for hairlosstreatment and addresses misconceptions about its use in hormone replacement therapy. It also touches on the safety and long-term effects of finasteride, with some users expressing skepticism and others defending its safety profile.
Hairloss discussion includes finasteride intolerance and questioning if Pyrilutamide is an alternative. Pyrilutamide not commercially available, but may be tolerable if approved since it's not a 5aR inhibitor.
Microneedling with exosomes is being considered for hair regrowth, but concerns exist about their effectiveness and safety, especially since exosomes degrade quickly and lack FDA approval. The user is seeking alternatives for non-responders to minoxidil and dutasteride, as exosomes may not provide additional benefits.
The conversation is about the effectiveness of hairlosstreatments like finasteride, dutasteride, and minoxidil. Users agree these treatments help maintain hair but don't guarantee miraculous regrowth, emphasizing early intervention for best results.
RU58841 is discussed as a topical anti-androgen for hairloss, but its effectiveness and safety are not well-documented, leading to mixed opinions and experiences among users. Some combine it with finasteride, but concerns about side effects and lack of FDA approval limit its popularity.
PP405 is the most promising future treatment for hairloss, aiming to reactivate dormant hair follicles. Clascoterone 5% is the most promising near-term drug, while current strategies include using finasteride or dutasteride to stabilize hairloss and minoxidil to stimulate growth.
There is no permanent cure for hairloss; treatments like finasteride, minoxidil, and hair transplants require ongoing use and are not universally effective. Genetic complexity and financial incentives for ongoing treatments hinder the development of a definitive cure.
UCLA's PP405 shows promise in reactivating dormant hair follicles for hairlosstreatment but is still in clinical trials. Minoxidil and finasteride remain common treatments until PP405 becomes available.
Various hair growth treatments were discussed, including microneedling, bimatoprost, setipiprant, stemoxydine, PGE2, CB-03-01, WNT Beta-Catenin upregulators, KY19382, topical estrogen, IGF-1, GH, MK-677, oral castor oil, fisetin, resveratrol, cetrizine, and lactic acid. Users shared experiences and sources for these treatments, with some expressing interest in topical solutions and others noting the lack of FDA approval or scientific evidence for certain options.
The potential risks and benefits of using Dutasteride as a hairlosstreatment, compared to using Finasteride or other treatments like RU58841 or Accutane. People discussed their personal experiences with these treatments and shared advice on how to proceed.
Amplifica starting clinical trials for new hairloss drug. SCUBE3 protein discovered, stimulates hair growth, could be alternative to Minoxidil and Finasteride.
The post and conversation discuss Verteporfin's potential as a hairlosstreatment. It's shown promise in regrowing hair after transplants and might be effective with microneedling.
Exosomes from Musely are being discussed as a topical hairlosstreatment containing ingredients like latanoprost, caffeine, cetirizine, melatonin, vitamin D3, vitamin E, and biotin. Users are curious about its effectiveness and potential side effects, noting it may take 4-6 months to see results.